Fri, May 12, 2023
Thu, May 11, 2023
Wed, May 10, 2023

Matthew Barcus Reiterated (XLO) at Strong Buy and Held Target at $7 on, May 11th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-7-on-may-11th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Barcus of Chardan Capital, Reiterated "Xilio Therapeutics, Inc." (XLO) at Strong Buy and Held Target at $7 on, May 11th, 2023.

Matthew has made no other calls on XLO in the last 4 months.



There is 1 other peer that has a rating on XLO. Out of the 1 peers that are also analyzing XLO, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Michael Ulz of "Morgan Stanley" Maintained at Buy with Decreased Target to $10 on, Friday, January 27th, 2023

Publication Contributing Sources